Position in MYGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$326,730
-$860,662 QoQ
Shares Held
57,221
-78.3% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,851,050,368 across 35 Diagnostics & Research names. MYGN ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,503,527 | $4,263,328,287 | |
| 2 | NTRA |
Natera, Inc.
|
12,865,346 | $3,492,298,164 | |
| 3 | DHR |
Danaher Corp /De/
|
12,185,400 | $2,321,074,982 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
6,139,775 | $1,186,327,314 | |
| 5 | WAT |
Waters Corp /De/
|
2,158,391 | $809,482,952 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,520,438 | $746,156,824 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
755,791 | $397,878,607 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,268,384 | $355,147,520 |
All Filings in MYGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,730 | 57,221 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,187,392 | 263,865 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,337,417 | 380,068 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,992,635 | 552,232 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $3,534,174 | 665,570 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,870,585 | 549,108 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $5,830,093 | 425,244 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $15,506,298 | 566,130 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $14,033,214 | 573,721 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,235,911 | 104,874 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $2,830,805 | 147,900 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,152,038 | 134,167 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,098,655 | 133,678 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,667,134 | 157,862 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2,039,788 | 140,686 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,093,878 | 162,153 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,433,791 | 299,053 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $19,909,082 | 790,043 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $19,664,750 | 712,491 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $24,144,135 | 747,728 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $24,260,091 | 793,332 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $8,543,233 | 280,566 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,198,710 | 364,123 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $8,855,214 | 679,081 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,101,944 | 449,907 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $4,673,672 | 326,602 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||